[Immunotherapy for malignant pleural mesothelioma]

Tidsskr Nor Laegeforen. 2021 Sep 6:141. doi: 10.4045/tidsskr.21.0503. Print 2021 Sep 7.

[Article in Norwegian]

Authors

Saima Jamil Farooqi, Maria Moksnes Bjaanæs, Åslaug Helland, Vilde Drageset Haakensen

PMID: 34505475
DOI: 10.4045/tidsskr.21.0503

No abstract available

MeSH terms

Humans
Immunologic Factors
Immunotherapy
Mesothelioma, Malignant*

Substances

Immunologic Factors